Current Environment: Production

Alicia Casey | Certifications

  • American Board of Pediatrics (General)
  • American Board of Pediatrics (Pulmonology)

Alicia Casey | Professional History

Dr. Casey serves as an expert for the Department of Medicine for Boston Children's Hospital Precision Medicine Service. For more information about the Precision Medicine Service please visit bostonchildrens.org/precisionmed.

Alicia Casey | Publications

  1. Genetic Testing Utilization in the U.S. Registry for Childhood Interstitial and Diffuse Lung Diseases. Pediatr Pulmonol. 2025 Apr; 60(4):e71073. View Genetic Testing Utilization in the U.S. Registry for Childhood Interstitial and Diffuse Lung Diseases. Abstract

  2. Clinical Presentation and Diagnostic Evaluation of Vaping Related Lung Injury in Youth. Respirology. 2025 Mar 26. View Clinical Presentation and Diagnostic Evaluation of Vaping Related Lung Injury in Youth. Abstract

  3. A progranulin variant causing childhood interstitial lung disease responsive to anti-TNF-a biologic therapy. Med. 2025 Feb 25; 100607. View A progranulin variant causing childhood interstitial lung disease responsive to anti-TNF-a biologic therapy. Abstract

  4. Innovations in Childhood Interstitial and Diffuse Lung Disease. Clin Chest Med. 2024 Sep; 45(3):695-715. View Innovations in Childhood Interstitial and Diffuse Lung Disease. Abstract

  5. ATP binding cassette member A3 (ABCA3): coming of age. Thorax. 2023 06; 78(6):533-534. View ATP binding cassette member A3 (ABCA3): coming of age. Abstract

  6. Expectations versus reality: Understanding the accuracy of impressions made during virtual interviews of pediatric pulmonary fellowship programs. Pediatr Pulmonol. 2023 01; 58(1):306-314. View Expectations versus reality: Understanding the accuracy of impressions made during virtual interviews of pediatric pulmonary fellowship programs. Abstract

  7. Pediatric EVALI in the Age of COVID-19/MIS-C: Diagnostic Considerations. Hosp Pediatr. 2022 07 01; 12(7):e249-e254. View Pediatric EVALI in the Age of COVID-19/MIS-C: Diagnostic Considerations. Abstract

  8. The Clinical Assessment of Vaping Exposure. J Addict Med. 2020 12; 14(6):446-450. View The Clinical Assessment of Vaping Exposure. Abstract

  9. Vaping and e-cigarette use. Mysterious lung manifestations and an epidemic. Curr Opin Immunol. 2020 10; 66:143-150. View Vaping and e-cigarette use. Mysterious lung manifestations and an epidemic. Abstract

  10. MRSA septic pulmonary emboli presenting as isolated focal chest pain in an adolescent. Radiol Case Rep. 2020 Nov; 15(11):2406-2409. View MRSA septic pulmonary emboli presenting as isolated focal chest pain in an adolescent. Abstract

  11. A review of toxic effects of electronic cigarettes/vaping in adolescents and young adults. Crit Rev Toxicol. 2020 07; 50(6):531-538. View A review of toxic effects of electronic cigarettes/vaping in adolescents and young adults. Abstract

  12. Overview of the ChILD Research Network: A roadmap for progress and success in defining rare diseases. Pediatr Pulmonol. 2020 07; 55(7):1819-1827. View Overview of the ChILD Research Network: A roadmap for progress and success in defining rare diseases. Abstract

  13. Neuroendocrine Cell Hyperplasia of Infancy. Clinical Score and Comorbidities. Ann Am Thorac Soc. 2020 06; 17(6):724-728. View Neuroendocrine Cell Hyperplasia of Infancy. Clinical Score and Comorbidities. Abstract

  14. Characterization of SETD1A haploinsufficiency in humans and Drosophila defines a novel neurodevelopmental syndrome. Mol Psychiatry. 2021 06; 26(6):2013-2024. View Characterization of SETD1A haploinsufficiency in humans and Drosophila defines a novel neurodevelopmental syndrome. Abstract

  15. Case series: Adolescent victims of the vaping public health crisis with pulmonary complications. Pediatr Pulmonol. 2020 05; 55(5):1224-1236. View Case series: Adolescent victims of the vaping public health crisis with pulmonary complications. Abstract

  16. Postinfectious Bronchiolitis Obliterans in Children: Diagnostic Workup and Therapeutic Options: A Workshop Report. Can Respir J. 2020; 2020:5852827. View Postinfectious Bronchiolitis Obliterans in Children: Diagnostic Workup and Therapeutic Options: A Workshop Report. Abstract

  17. An old flame: The e-cigarette industry advertises, addicts, and challenges scientific evidence using the cigarette industry playbook. Pediatr Pulmonol. 2020 02; 55(2):272-275. View An old flame: The e-cigarette industry advertises, addicts, and challenges scientific evidence using the cigarette industry playbook. Abstract

  18. Expanded access with intravenous hydroxypropyl-ß-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis. Orphanet J Rare Dis. 2019 10 21; 14(1):228. View Expanded access with intravenous hydroxypropyl-ß-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis. Abstract

  19. Emergent high fatality lung disease in systemic juvenile arthritis. Ann Rheum Dis. 2019 12; 78(12):1722-1731. View Emergent high fatality lung disease in systemic juvenile arthritis. Abstract

  20. Pediatric Hemoptysis without Bronchiectasis or Cardiac Disease: Etiology, Recurrence, and Mortality. J Pediatr. 2019 11; 214:66-70. View Pediatric Hemoptysis without Bronchiectasis or Cardiac Disease: Etiology, Recurrence, and Mortality. Abstract

  21. Pulmonary hemorrhage in infancy: A 10-year single-center experience. Pediatr Pulmonol. 2018 11; 53(11):1559-1564. View Pulmonary hemorrhage in infancy: A 10-year single-center experience. Abstract

  22. ATS Core Curriculum 2017: Part II. Pediatric Pulmonary Medicine. Ann Am Thorac Soc. 2017 08; 14(Suppl_2):S165-S181. View ATS Core Curriculum 2017: Part II. Pediatric Pulmonary Medicine. Abstract

  23. Divergent Function of Programmed Death-Ligand 1 in Donor Tissue versus Recipient Immune System in a Murine Model of Bronchiolitis Obliterans. Am J Pathol. 2017 Jun; 187(6):1368-1379. View Divergent Function of Programmed Death-Ligand 1 in Donor Tissue versus Recipient Immune System in a Murine Model of Bronchiolitis Obliterans. Abstract

  24. Congenital Chylothorax as the Initial Presentation of PTPN11-Associated Noonan Syndrome. J Pediatr. 2017 06; 185:248-248.e1. View Congenital Chylothorax as the Initial Presentation of PTPN11-Associated Noonan Syndrome. Abstract

  25. Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTR. J Cyst Fibros. 2017 May; 16(3):371-379. View Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTR. Abstract

  26. Pulmonary Vasculopathy Associated with FIGF Gene Mutation. Am J Pathol. 2017 Jan; 187(1):25-32. View Pulmonary Vasculopathy Associated with FIGF Gene Mutation. Abstract

  27. Current Update on Interstitial Lung Disease of Infancy: New Classification System, Diagnostic Evaluation, Imaging Algorithms, Imaging Findings, and Prognosis. Radiol Clin North Am. 2016 Nov; 54(6):1065-1076. View Current Update on Interstitial Lung Disease of Infancy: New Classification System, Diagnostic Evaluation, Imaging Algorithms, Imaging Findings, and Prognosis. Abstract

  28. Lung Pathology in Pediatric Pulmonary Vein Stenosis. Pediatr Dev Pathol. 2016 May-Jun; 19(3):219-29. View Lung Pathology in Pediatric Pulmonary Vein Stenosis. Abstract

  29. Bone marrow-derived multipotent stromal cells attenuate inflammation in obliterative airway disease in mouse tracheal allografts. Stem Cells Int. 2014; 2014:468927. View Bone marrow-derived multipotent stromal cells attenuate inflammation in obliterative airway disease in mouse tracheal allografts. Abstract

  30. Genotype-phenotype correlations for infants and children with ABCA3 deficiency. Am J Respir Crit Care Med. 2014 Jun 15; 189(12):1538-43. View Genotype-phenotype correlations for infants and children with ABCA3 deficiency. Abstract

  31. Primary Ciliary Dyskinesia: An Update on New Diagnostic Modalities and Review of the Literature. Pediatr Allergy Immunol Pulmonol. 2014 Jun 01; 27(2):51-59. View Primary Ciliary Dyskinesia: An Update on New Diagnostic Modalities and Review of the Literature. Abstract

  32. Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity. Am J Physiol Heart Circ Physiol. 2014 Jul 01; 307(1):H110-7. View Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity. Abstract

  33. Impact of cilia ultrastructural examination on the diagnosis of primary ciliary dyskinesia. Pediatr Dev Pathol. 2013 Sep-Oct; 16(5):321-6. View Impact of cilia ultrastructural examination on the diagnosis of primary ciliary dyskinesia. Abstract

  34. Activation of NFAT signaling establishes a tumorigenic microenvironment through cell autonomous and non-cell autonomous mechanisms. Oncogene. 2014 Apr 03; 33(14):1840-9. View Activation of NFAT signaling establishes a tumorigenic microenvironment through cell autonomous and non-cell autonomous mechanisms. Abstract

  35. Chest radiographic and CT evaluation of lung abnormalities in pediatric patients with laryngeal cleft. Pediatr Pulmonol. 2011 Nov; 46(11):1128-33. View Chest radiographic and CT evaluation of lung abnormalities in pediatric patients with laryngeal cleft. Abstract

  36. Expiratory volumetric MDCT evaluation of air trapping in pediatric patients with and without tracheomalacia. AJR Am J Roentgenol. 2010 May; 194(5):1210-5. View Expiratory volumetric MDCT evaluation of air trapping in pediatric patients with and without tracheomalacia. Abstract

  37. Vomiting and rapid weight loss in a man with newly diagnosed HIV infection. Clin Infect Dis. 2005 Oct 15; 41(8):1157-8, 1196-7. View Vomiting and rapid weight loss in a man with newly diagnosed HIV infection. Abstract

BESbswy
BESbswy